Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brooke Bernhardt

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|February 24, 2015
The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology GroupElizabeth G Salazar, M Brooke Bernhardt, Yimei Li, et al.
The Oncologist|December 9, 2023
Methotrexate Scarcity Among Children's Oncology Group Institutions: Results of a Multinational SurveySarah Menig, Olga Militano, Andrew Ostrenga, et al.
Pharmaceutics|June 27, 2025
Automated 3D Printing-Based Non-Sterile Compounding Technology for Pediatric Corticosteroid Dosage Forms in a Health System Pharmacy SettingM Brooke Bernhardt, Farnaz Shokraneh, Ludmila Hrizanovska, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 25, 2025
Advancing non-sterile pediatric pharmacotherapy through automated compounding and 3D printing of ondansetron hcl dihydrate dosage formsMahsa Bahman, M Brooke Bernhardt, Cynthia A Brasher, et al.
American Journal of Hematology|November 10, 2017
Hispanic ethnicity as a risk factor for requiring glucarpidase rescue in pediatric patients receiving high-dose methotrexateEric S Schafer, M Brooke Bernhardt, Kate E Reichert, et al.
Pediatric Blood & Cancer|September 30, 2014
Agreement among measurements and estimations of glomerular filtration in children with cancerM Brooke Bernhardt, Brady S Moffett, Michael Johnson, et al.
Pharmacotherapy|February 10, 2023
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemiaMark Zobeck, M Brooke Bernhardt, Kala Y Kamdar, et al.
Pediatric Hematology and Oncology|January 10, 2023
Treatment of Langerhans cell histiocytosis with subcutaneous cytarabineOlive S Eckstein, M Brooke Bernhardt, Chelsey G Hood, et al.
Pediatric Blood & Cancer|July 2, 2020
Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortageRoss Mangum, M Brooke Bernhardt, W Susan Cheng, et al.
Pediatric Blood & Cancer|March 31, 2021
Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 geneMark C Zobeck, M Brooke Bernhardt, Kala Y Kamdar, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|February 24, 2015
The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology GroupElizabeth G Salazar, M Brooke Bernhardt, Yimei Li, et al.
The Oncologist|December 9, 2023
Methotrexate Scarcity Among Children's Oncology Group Institutions: Results of a Multinational SurveySarah Menig, Olga Militano, Andrew Ostrenga, et al.
Pharmaceutics|June 27, 2025
Automated 3D Printing-Based Non-Sterile Compounding Technology for Pediatric Corticosteroid Dosage Forms in a Health System Pharmacy SettingM Brooke Bernhardt, Farnaz Shokraneh, Ludmila Hrizanovska, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 25, 2025
Advancing non-sterile pediatric pharmacotherapy through automated compounding and 3D printing of ondansetron hcl dihydrate dosage formsMahsa Bahman, M Brooke Bernhardt, Cynthia A Brasher, et al.
American Journal of Hematology|November 10, 2017
Hispanic ethnicity as a risk factor for requiring glucarpidase rescue in pediatric patients receiving high-dose methotrexateEric S Schafer, M Brooke Bernhardt, Kate E Reichert, et al.
Pediatric Blood & Cancer|September 30, 2014
Agreement among measurements and estimations of glomerular filtration in children with cancerM Brooke Bernhardt, Brady S Moffett, Michael Johnson, et al.
Pharmacotherapy|February 10, 2023
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemiaMark Zobeck, M Brooke Bernhardt, Kala Y Kamdar, et al.
Pediatric Hematology and Oncology|January 10, 2023
Treatment of Langerhans cell histiocytosis with subcutaneous cytarabineOlive S Eckstein, M Brooke Bernhardt, Chelsey G Hood, et al.
Pediatric Blood & Cancer|July 2, 2020
Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortageRoss Mangum, M Brooke Bernhardt, W Susan Cheng, et al.
Pediatric Blood & Cancer|March 31, 2021
Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 geneMark C Zobeck, M Brooke Bernhardt, Kala Y Kamdar, et al.
Pageof 5